Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347607 · ClinicalTrials.gov registry record · Phase 4
Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,700
- Enrollment target
NCT00347607: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT00347607 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 2,700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00347607, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,700 participants
- Enrollment target
Study Summary
After single, yearly, mass treatment of communities with azithromycin for active trachoma, what is the added effectiveness for reduction of trachoma and ocular C. trachomatis infection at one, two, and three years, relative to the added costs, of community-based surveillance and treatment of cases of severe trachoma (TI) semi-annually or every 4 months?
Interventions
- BEHAVIORAL community surveillance and re-treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2002-04 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00347607
The ClinicalTrials.gov registry entry for NCT00347607 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which community surveillance and re-treatment is the first listed.
NCT00347607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00347607 about?
NCT00347607 is a clinical study titled "Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania". After single, yearly, mass treatment of communities with azithromycin for active trachoma, what is the added effectiveness for reduction of trachoma and ocular C. trachomatis infection at one, two, and three years, relative to the added costs, of community-based surveillance and treatment of cases o...
What is the current status of trial NCT00347607?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,700 participants. The study started on 2002-04. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00347607?
The interventions under investigation include: community surveillance and re-treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00347607?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.